Home › Funds › Ally Bridge Group (NY) LLC › SLDB

Ally Bridge Group (NY) LLC position in SLDB

SOLID BIOSCIENCES INC COM NEW · Health Care

Ally Bridge Group (NY) LLC reported holding 255,959 shares of SLDB (SOLID BIOSCIENCES INC COM NEW) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 2.26% of its reported portfolio and ranking #15 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed SLDB holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)255.96K sh
Reported value held$2.56M
Portfolio Weight2.26%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's SLDB position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in SLDB in Q2 2025 at 724,000 shares (US$3.5M). The position peaked in Q1 2026 at 766,974 shares, worth US$5.5M. Across 5 filings, Ally Bridge Group (NY) LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 255,959 shares valued at US$2.6M — a reduction of -511,015 shares quarter over quarter.. Notable position changes include a 85% increase in Q1 2026 (shares rose 39% over the following quarter), a 67% trim in Q2 2026 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 724.00K $3.53M New
Q3 2025 549.18K $3.39M Reduce
Q4 2025 413.62K $2.33M Reduce
Q1 2026 766.97K $5.52M Add
Q2 2026 255.96K $2.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLDB and 13F data

SLDB (SOLID BIOSCIENCES INC COM NEW) is a Health Care company. 48 other funds we track also report a position in SLDB — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$120.2M), PERCEPTIVE ADVISORS LLC (US$118.9M), Bain Capital Life Sciences Investors, LLC (US$98.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLDB

All SLDB fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held SLDB?

Ally Bridge Group (NY) LLC has disclosed SLDB holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Ally Bridge Group (NY) LLC's current position in SLDB?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 255.96K shares of SLDB (SOLID BIOSCIENCES INC COM NEW), valued at $2.56M, representing 2.26% of its reported portfolio and ranking #15.

Has Ally Bridge Group (NY) LLC been buying or selling SLDB?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC reduced its position in SLDB. The position peaked in Q1 2026 at 766.97K shares.

Which other funds hold SLDB?

Other major institutional holders of SLDB include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.